Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-08 Snodgres Jon Chief Financial Officer Option exercise · Stock Option (Right to Buy) +2,952 13,707
2022-03-08 Snodgres Jon Chief Financial Officer Option exercise · Stock Option (Right to Buy) +1,214 2,574
2022-02-28 Snodgres Jon Chief Financial Officer Shares withheld for taxes −661 $196.70 $130K 32,279
2022-02-28 Snodgres Jon Chief Financial Officer Grant or award +5,922 38,201
2022-02-28 Snodgres Jon Chief Financial Officer Shares withheld for taxes −2,468 $196.70 $485K 35,733
2022-02-27 Snodgres Jon Chief Financial Officer Shares withheld for taxes −695 $196.70 $137K 32,940
2022-02-24 Snodgres Jon Chief Financial Officer Grant or award +3,443 33,904
2022-02-24 Snodgres Jon Chief Financial Officer Shares withheld for taxes −269 $189.21 $51K 33,635
2022-02-24 Snodgres Jon Chief Financial Officer Grant or award · Stock Option (Right to Buy) +4,410 4,410
2022-02-17 Snodgres Jon Chief Financial Officer Grant or award +900 30,793
2022-02-17 Snodgres Jon Chief Financial Officer Shares withheld for taxes −332 $182.42 $61K 30,461

Page 2 of 2 · 31 trades